Cooperative Trials Group for Neuro-Oncology
In research, Cooperative Trials Group for Neuro-Oncology stands highest in Health Sciences (#6,175 of 11,982 worldwide) and Medicine (#5,664 of 10,443 worldwide), 2022–2025.
- World rank, 2022–2025
- #11,248 of 28,054 · #13,459 all time
- Rank in Australia
- #186 of 391
- Research works
- 694 ▲ 84% vs 2013–17
- Citations
- 16k 23.2 per fractional work
- Top-10% rate
- 22.3% record average 16.5%
- Open access
- 49% world 28%
What is Cooperative Trials Group for Neuro-Oncology known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #6,175 of 11,982 | 19.8% | 113 | #5907 | |
| MedicineField | #5,664 of 10,443 | 19.0% | 99 | #5213 |
Each strip is that field’s whole ranked pool, with the notch where Cooperative Trials Group for Neuro-Oncology sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 3.5×. Every wedge is a field page.
- Neuroscience 3.5×
- Veterinary 2.8×
- Medicine 2.3×
- Psychology 1.9×
- Health Professions 1.8×
- Immunology and Microbiology 1.5×
- Biochemistry, Genetics and Molecular Biology 1.2×
- Mathematics 1.2×
- Nursing 1.1×
- Dentistry 1.1×
- Economics, Econometrics and Finance 0.9×
- Decision Sciences 0.8×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Computer Science 0.6×
- Social Sciences 0.5×
- Environmental Science 0.5×
- Physics and Astronomy 0.5×
- Earth and Planetary Sciences 0.5×
- Chemistry 0.4×
- Business, Management and Accounting 0.4×
- Arts and Humanities 0.4×
- Agricultural and Biological Sciences 0.3×
- Engineering 0.3×
- Chemical Engineering 0.3×
- Materials Science 0.3×
- Energy 0.1×
Which keywords describe research at Cooperative Trials Group for Neuro-Oncology?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Quality of Life, Neurological Disorders, Inflammation, Cardiovascular Disease, Depression, Insulin Resistance and Health-related Quality of Life.
- Neuromyelitis Optica
- Brain Development
- Prognosis
- Survival Analysis
- Obstructive Sleep Apnea
- Psychosocial Interventions
- Patient-Reported Outcomes
- Fatigue
- Diagnostic Criteria
- Hypertension
- Clinical Trials
- Neuroimaging
- Physical Activity
- Anxiety
- Public Health
- Chemotherapy
- Risk Factors
- Neurological Disorders
- Deep Learning
- Inflammation
- Epidemiology
- Quality of Life
- Cardiovascular Disease
- Depression
- Insulin Resistance
- Mortality
- Immunotherapy
- Obesity
- Metabolic Syndrome
- Health-related Quality of Life
- Genetics
- Neurodegeneration
- Cancer Survivorship
- Radiotherapy
- Prevalence
- Cognitive Impairment
- Sleep-Disordered Breathing
- Circadian Rhythms
- Mitochondrial Dysfunction
- Multiple Sclerosis
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology16▲ 1.84×72 topics
- Inflammation10▲ 2.2×47 topics
- Quality of Life10▲ 3.1×36 topics
- Deep Learning9◆ 1.11×43 topics
- Cardiovascular Disease8▲ 3.2×27 topics
- Neurological Disorders7▲ 5.5×15 topics
- Depression7▲ 3.4×14 topics
- Risk Factors6▲ 2.2×25 topics
- Insulin Resistance5▲ 5.1×9 topics
- Chemotherapy5▲ 3.1×16 topics
- Mortality5▲ 3.8×10 topics
- Public Health5▲ 1.52×22 topics
- Immunotherapy5▲ 2.9×16 topics
- Anxiety4▲ 4.3×6 topics
- Obesity4▲ 2.6×15 topics
- Physical Activity4▲ 4.0×6 topics
- Metabolic Syndrome4▲ 2.3×17 topics
- Neuroimaging4▲ 7.0×10 topics
- Health-related Quality of Life4▲ 7.9×4 topics
- Clinical Trials4▲ 2.7×15 topics
- Genetics4▲ 2.5×17 topics
- Hypertension4▲ 5.8×7 topics
- Neurodegeneration4▲ 5.6×8 topics
- Diagnostic Criteria4▲ 7.5×6 topics
- Cancer Survivorship4▲ 22×2 topics
- Fatigue4▲ 13×2 topics
- Radiotherapy4▲ 4.1×9 topics
- Patient-Reported Outcomes3▲ 28×1 topic
- Prevalence3▲ 3.8×13 topics
- Psychosocial Interventions3▲ 28×1 topic
- Cognitive Impairment3▲ 5.8×8 topics
- Obstructive Sleep Apnea3▲ 31×1 topic
- Sleep-Disordered Breathing3▲ 31×1 topic
- Survival Analysis3▲ 5.1×6 topics
- Circadian Rhythms3▲ 12×2 topics
- Prognosis3▲ 3.9×9 topics
- Mitochondrial Dysfunction3▲ 4.2×6 topics
- Brain Development2▲ 6.0×6 topics
- Multiple Sclerosis2▲ 29×1 topic
- Neuromyelitis Optica2▲ 29×1 topic
Which research topics does Cooperative Trials Group for Neuro-Oncology publish most on?
By volume in 2022–2025: Cancer survivorship and care, Obstructive Sleep Apnea Research, Multiple Sclerosis Research Studies and Advanced Neuroimaging Techniques and Applications.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer survivorship and care Oncology 3 works
- 2 Obstructive Sleep Apnea Research Physiology 3 works
- 3 Multiple Sclerosis Research Studies Pathology and Forensic Medicine 2 works
- 4 Advanced Neuroimaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 2 works
- 5 Sleep and Wakefulness Research Cognitive Neuroscience 2 works
- 6 Diet and metabolism studies Physiology 1 works
- 7 Sleep and related disorders Experimental and Cognitive Psychology 1 works
- 8 Amyotrophic Lateral Sclerosis Research Neurology 1 works
- 9 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 10 Global trade, sustainability, and social impact Strategy and Management 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cooperative Trials Group for Neuro-Oncology's research output changed?
Output in 2018–2022 was 84% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Camperdown
- Sydney Local Health District
- Sydney South West Area Health Service
- Institute for Musculoskeletal Health
- Chris O’Brien Lifehouse
- King George V Memorial Hospital
- Australia New Zealand Gynaecological Oncology Group
- Australian and New Zealand Urogenital and Prostate Cancer Trials Group
- Clinical Oncological Society of Australia
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.